IFNAR1 and herpes simplex encephalitis: Both heterozygosity and homozygosity for IFNAR1 variants should be considered in patients presenting with severe viral illnesses, such as LAV disease, critical COVID-19 pneumonia, JEV encephalitis, and HSE.